MLchartDataset catalogue

OvaRex

Term · Oncology and biomedicine · MLC-T-ONC-006188

A monoclonal antibody that is being studied in the treatment of ovarian cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. OvaRex binds to the CA-125 antigen, which is found on most ovarian cancer cells. Also called oregovomab.

Table 1. Record
IdentifierMLC-T-ONC-006188
FieldOncology and biomedicine
Synonymsoregovomab
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-006188",
  "term": "OvaRex",
  "field": "Oncology and biomedicine",
  "definition": "A monoclonal antibody that is being studied in the treatment of ovarian cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. OvaRex binds to the CA-125 antigen, which is found on most ovarian cancer cells. Also called oregovomab.",
  "synonyms": [
    "oregovomab"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/ovarex/"
}

Record 12,401 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.